← Evidence map

ReviewFrontiers in pharmacology2022

Advances in RIPK1 kinase inhibitors.

Lu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36249746